Products
2660 products
| Code | Description | Unit |
|---|---|---|
| EPY0000822 | Molsidomine impurity B - N-Nitrosomorpholine | EP unit |
| EPY0000823 | Molsidomine impurity D - morpholine-4-carbaldehyde | EP unit |
| EPY0000824 | Niflumic acid | EP unit |
| EPY0000825 | Niflumic acid impurity A - 2-chloropyridine-3-carboxylic acid | EP unit |
| EPY0000826 | Niflumic acid impurity B - 2-hydroxy-N-(3-(trifluoromethyl)phenyl)pyridine-3-carboxamide | EP unit |
| EPY0000827 | Niflumic acid impurity E - 6-((3-(trifluoromethyl)phenyl)amino)pyridine-3-carboxylic acid | EP unit |
| EPY0000828 | Sertraline hydrochloride | EP unit |
| EPY0000829 | Nilutamide | EP unit |
| EPY0000831 | Dihydroergotamine for peak identification | EP unit |
| EPY0000832 | Alfuzosin for system suitability | EP unit |
| EPY0000833 | Clopamide | EP unit |
| EPY0000834 | Valaciclovir hydrochloride (anhydrous) | EP unit |
| EPY0000835 | Pantoprazole sodium sesquihydrate | EP unit |
| EPY0000836 | Nifuroxazide | EP unit |
| EPY0000837 | Triamterene | EP unit |
| EPY0000838 | Doxepin hydrochloride | EP unit |
| EPY0000839 | Iobenguane sulphate - Reference Spectrum | EP unit |
| EPY0000842 | Acemetacine impurity mixture | EP unit |
| EPY0000843 | Altizide impurity B - 3-[(2,2-dimethoxyethyl)sulphanyl]prop-1-ene | EP unit |
| EPY0000845 | Atropine for peak identification | EP unit |
| EPY0000846 | Carprofen for veterinary use | EP unit |
| EPY0000848 | Clopamide for system suitability | EP unit |
| EPY0000849 | Clotrimazole for peak identification | EP unit |
| EPY0000851 | Doxepin for system suitability | EP unit |
| EPY0000852 | Estradiol benzoate for system suitability | EP unit |
| EPY0000853 | Fluvoxamine for system suitability | EP unit |
| EPY0000854 | Fluvoxamine maleate | EP unit |
| EPY0000855 | Citalopram for system suitability | EP unit |
| EPY0000858 | Isoflurane | EP unit |
| EPY0000860 | Liothyronine for peak identification | EP unit |
| EPY0000861 | Methyltestosterone for system suitability | EP unit |
| EPY0000862 | Mianserin hydrochloride for system suitability | EP unit |
| EPY0000866 | Sertraline for peak identification | EP unit |
| EPY0000867 | Sertraline for system suitability | EP unit |
| EPY0000868 | Streptokinase for system suitability | EP unit |
| EPY0000870 | Triamterene impurity B - 2,7-diamino-6-phenylpteridin-4-ol | EP unit |
| EPY0000877 | Bisoprolol for peak identification | EP unit |
| EPY0000878 | Atropine | EP unit |
| EPY0000879 | Desflurance - Reference Spectrum | EP unit |
| EPY0000880 | Indinavir sulphate - Reference Spectrum | EP unit |
| EPY0000881 | Ibuprofen for peak identification | EP unit |
| EPY0000882 | Adrenaline | EP unit |
| EPY0000883 | Adrenaline with impurity F | EP unit |
| EPY0000884 | Carprofen for system suitability | EP unit |
| EPY0000885 | Clodronate impurity D - (chloromethylene)bis(phosphonic acid) | EP unit |
| EPY0000886 | Cyclizine impurity A - 1-methylpiperazine | EP unit |
| EPY0000887 | Cyclizine impurity B - diphenylmethanol (benzhydrol) | EP unit |
| EPY0000888 | Clodronate disodium tetrahydrate | EP unit |
| EPY0000889 | Flucloxacillin impurity C - 6-aminopenicillanic acid | EP unit |
| EPY0000890 | Flucloxacillin impurity D - 3-(2-chloro-6-fluorophenyl)-5-methylisoxazole-4-carboxylic acid | EP unit |
| EPY0000891 | Flucloxacillin impurity E - 6-aminopenicillanic acid flucloxacillin amide | EP unit |
| EPY0000892 | Flucloxacillin magnesium octahydrate | EP unit |
| EPY0000893 | Imipramine for system suitability | EP unit |
| EPY0000894 | Nilutamide impurity B - 4-nitro-3-(trifluoromethyl)aniline | EP unit |
| EPY0000895 | Orciprenaline for system suitability | EP unit |
| EPY0000896 | Racecadotril | EP unit |
| EPY0000897 | Racecadotril impurity A - Ethanethioic acid | EP unit |
| EPY0000898 | Racecadotril impurity G - benzyl[[(2RS)-2-benzyl-3-sulfanylpropanoyl]amino]acetate | EP unit |
| EPY0000899 | Tinidazole impurity A - 2-methyl-5-nitro-1H-imidazole | EP unit |
| EPY0000902 | Racecadotril for peak identification | EP unit |
| EPY0000910 | Methylphenidate impurity mixture | EP unit |
| EPY0000912 | Paraffin (Yellow soft) | EP unit |
| EPY0000913 | Paraffin (White soft) | EP unit |
| EPY0000915 | Hypromellose phthalate | EP unit |
| EPY0000916 | Fluvoxamine impurity D - 5-methoxy-1-[4-(trifluoromethyl)phenyl]pentan-1-one | EP unit |
| EPY0001001 | Pantoprazole for system suitability | EP unit |
| EPY0001002 | Tetracaine for system suitability | EP unit |
| EPY0001003 | Telmisartan for system suitability | EP unit |
| EPY0001004 | Dydrogesterone | EP unit |
| EPY0001005 | Dydrogesterone impurity A - 9 | EP unit |
| EPY0001006 | Dydrogesterone impurity B - pregna-4,6-diene-3,20-dione | EP unit |
| EPY0001007 | Citalopram hydrochloride | EP unit |
| EPY0001008 | Citalopram hydrobromide | EP unit |
| EPY0001009 | Quercetin dihydrate | EP unit |
| EPY0001010 | Ginkgolic Acid | EP unit |
| EPY0001011 | Spanish sage oil for peak identification | EP unit |
| EPY0001012 | Ginkgo dry extract for peak identification | EP unit |
| EPY0001013 | Ferulic acid | EP unit |
| EPY0001014 | Amphotericin B for peak identification | EP unit |
| EPY0001015 | Norfloxacin for system suitability | EP unit |
| EPY0001018 | Cisplatin impurity A - trans-diamminedichloroplatinium (II) | EP unit |
| EPY0001019 | Cisplatin impurity B - amminetrichloroplatinate (-) | EP unit |
| EPY0001020 | Iopromide | EP unit |
| EPY0001021 | Iopromide for system suitability 1 | EP unit |
| EPY0001022 | Iopromide for system suitability 2 | EP unit |
| EPY0001023 | Nicotine for system suitability | EP unit |
| EPY0001024 | Ascorbic acid impurity C - D-xylo-hex-2-ulosonic acid (D-sorbosonic acid) | EP unit |
| EPY0001025 | Benazepril hydrochloride | EP unit |
| EPY0001026 | Benazepril impurity A - [(3R)-3-[[(1R)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetic acid | EP unit |
| EPY0001027 | Betamethasone for system suitability | EP unit |
| EPY0001028 | Esomeprazole magnesium trihydrate | EP unit |
| EPY0001029 | Ginseng dry extract | EP unit |
| EPY0001030 | Lamotrigine | EP unit |
| EPY0001031 | Lamotrigine for peak identification | EP unit |
| EPY0001032 | Lamotrigine impurity E - 2,3-dichlorobenzoic acid | EP unit |
| EPY0001033 | Levodropropizine impurity B - 1-phenylpiperazine | EP unit |
| EPY0001034 | Lynestrenol for peak identification | EP unit |
| EPY0001035 | Meloxicam impurity A - ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide | EP unit |
| EPY0001036 | Meloxicam impurity B - 5-methylthiazol-2-amine | EP unit |
| EPY0001037 | Meloxicam impurity C - N-[(2Z)-3,5-dimethylthiazol-2(3H)-ylidene]-4-hydroxy-2-methyl-2H-1,2- benzothiazine-3-carboxamide 1,1-dioxide | EP unit |